Fresenius Kabi Breaks Into Brazilian Biosimilars Market

Strikes State-Private Adalimumab Deal With Fiocruz/Bio-Manguinhos And Bionovis

 
• By Rosalind Rei
  
Brazil health ministry sign
Fresenius’ Idacio will be the company’s first biosimilar on the Brazilian market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business